Thanks to the increased curiosity in ideas like the metaverse, virtual reality (VR) stocks are among the most sought-after investment choices available these days. Reflecting a yearly increase of around 42%, the VR market size is expected to reach about $22.81 billion in 2024 and soar to $131.93 billion by 2029. Another source forecasts the
Investing in undervalued stocks gives investors an edge in capitalizing on companies with high growth potential. Listing these stocks involves scanning the fundamentals, which helps mark potential the market might overlook. Indeed, fundamentals like top-line growth, profit margins, and strategic initiatives reflect a company’s true value. Here, the focus is on three undervalued stocks. To begin with, the
After what seemed like a slam-dunk victory for former President Donald Trump, circumstances in the political realm have become much more exciting. It’s not entirely clear that Vice President Kamala Harris can do enough to change the dynamics of the race to her favor. Still, polling data shows that she’s closing the gap to Trump.
Small-cap stocks have gotten a bad rap lately, and I get it. Most of them have severely underperformed the broader market rally we’ve seen. Sky-high interest rates have crushed the growth prospects for many of these fledgling companies. And let’s be real. A lot of small-caps are unprofitable anyway, so why even bother investing in
Broadcom’s (NASDAQ:AVGO) stock is an optimistic buy in line with high AI and networking capabilities. In fiscal Q2 2024, Broadcom had net revenue of $12.5 billion, a 43% year-over-year (YOY) increase. Excluding VMware, Broadcom’s revenue grew by 12%, primarily due to a 280% surge in AI revenue. Next year, Broadcom’s AI and networking revenue may grow 40%
Retail sales are a closely watched economic indicator every month. For the last year, the monthly and year-over-year (YOY) numbers have been weak at best. But there’s a bigger problem. The headline number doesn’t tell the full story of what ails retail stocks. When adjusted for inflation, the retail sales numbers are negative. But you’re
After a weak July jobs report released Friday morning, in which unemployment unexpectedly spiked to 4.3%, Wall Street worries that the U.S. economy may plunge into a recession. On the face of it, those fears seem legit: The S&P 500 dropped 1.84%. The Nasdaq Composite lost 2.43%, knocking the tech-heavy index down more than 10%
Beauty stocks continue to shine as a lucrative investment opportunity, driven by consistent growth and innovation in the overall industry. The global cosmetics market is estimated to reach around $661 billion by 2032, increasing from $398 billion in 2023. That’s a compound annual growth rate (CAGR) of around 3.3% from 2024 to 2028, so the
If you’re looking for an index to buy-and-hold, you shouldn’t consider the Russell 2000. It makes no sense to follow a benchmark that has historically underperformed the S&P 500 and Nasdaq Composite for many years. However, this same underperforming index offers great investment opportunities. Stocks often find themselves in the Russell 2000 long before they
The stock market is taking a breather after a 20% run higher this year. According to Fidelity, that was mostly driven by tech stocks, which are up 25% year-to-date. Dig a little deep, though, and we see the S&P 500 is once again mostly driven up by the same forces that allowed the index to
Cannabis stocks have been through an extended period of depression. Overcapacity, regulatory headwinds, competition, and cash burn have contributed to the decline in the cannabis industry. However, markets react to extremes and I believe that cannabis stocks are undervalued. In addition to this, the regulatory environment is getting friendlier. Germany legalized recreational cannabis this year and I
Somewhat displaced by the association with shady cryptocurrencies, metaverse stocks and the broader metaverse universe should be viewed as a foundation in progress. It may or may not include alternate reality/virtual reality devices, but the building blocks are clear: GPUs, CPUs, content, content creation tools and blockchain tech at large for in-game digital assets. According
The IPO (initial public offering) market has gotten stronger in 2024, according to the Q2 2024 quarterly review from IPO specialist Renaissance Capital. That has resulted in a more buoyant market for secondary offerings. According to Renaissance, 39 IPOs raised nearly $9 billion in the second quarter, 35% higher than Q2 2023 and 324% higher
As we enter August, it’s time to start thinking about autumn. Back-to-school sales are on and it won’t be long before the days get shorter and the temperature grows colder. Of course, the stock market has been anything but tranquil this summer. Volatility continues to rule as investors shift money around and equities swing from
The growth and tech-heavy Nasdaq 100 index is in something of a significant correction at the moment. After hitting new all-time highs early in July, the benchmark Invesco QQQ ETF (NASDAQ:QQQ) has already pulled back close to 10% from its recent peak. There are several reasons for this. Several key tech leaders, such as Amazon
Sometimes the best way to jump into an industry like biotech is to follow the popular trades. Though that may go against the common advice of avoiding hype cycles and the fear of missing out, seeing which biotech stocks are experiencing the highest 24-hour trading volumes can be a quick way to learn which catalysts
At age 93, Warren Buffett presides over a vast stock portfolio currently worth nearly $400 billion. From humble beginnings, Buffett has created an equity portfolio that is the envy of the investment world. It is carefully tracked, meticulously analyzed and hotly debated by analysts, investors and media pundits. Many people try to replicate the Oracle
For many investors, recognizing that a stock is overvalued can be a difficult task when the broader media is lauding its accomplishments. Yet a healthy bump in earnings or revenue can often translate into an overvaluation in a short amount of time. This has been especially common in the artificial intelligence industry, which has led
Investing in biotech stocks is a thrilling ride. These innovative businesses developing breakthrough drugs can generate enormous profits for investors but also destroy significant value if their investigational therapies fail to make it to market. The pandemic focused a lot of attention on the sector. The SDPR S&P Biotech ETF (NYSEARCA:XBI) soared 49% in 2020,
There is no debating that stock market valuations are sky high right now. While the Federal Reserve hinted at rate cuts in September at its latest Federal Open Market Committee (FOMC) meeting, that doesn’t mean that stocks are setting up for new highs. Investors searching for safe stocks for a bear market should start their preparation
- « Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 735
- Next Page »